CD274 and neoplasm: The frequency of Ly6Chigh myeloid cells, the most prevalent immune cell among live cells in tumor at this early timepoint, was strongly reduced in both Paquinimod and anti-PD-L1 and Paquinimod groups compared with untreated and PD-L1 groups, respectively (Figure 4B).